Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

o2h ChaiTime - Discovery Club | featuring Cambridge Chemistry Club

Join us at Hauxton House for the o2h ChaiTime — Discovery Club.

​​We are excited to introduce o2h ChaiTime — Discovery Club - an invite-only forum designed to bring together Medicinal Chemists and Drug Discovery leaders for an open, peer-led discussion on emerging therapeutic areas and modalities.

Featuring the Cambridge Chemistry Club, we are bringing together a curated group of biotech leaders and decision-makers to present and discuss emerging modalities, evolving drug discovery strategies, and real-world insights across diverse therapeutic areas.

RxCelerate launches RxPlorer™: A new protein metastate discovery platform, unlocking new possibilities for screening against undruggable targets

• Cutting-edge platform technology leveraging advanced molecular dynamics to uncover protein metastates and reveal novel binding sites in difficult to target proteins.
• Combining RxPlorer™ with our in vitro capabilities, RxCelerate can deliver rapid hit identification and screening in 2 months.

Cambridge, UK and Cambridge, MA – 24/3/26 1pm GMT

Winners of the One Nucleus Awards 2026

We are pleased to announce the winners of the One Nucleus Awards 2026! The awards took place on 29 March in London.

The One Nucleus Award categories are structured to reflect that breadth of R&D, investment, service provision and enabling support across the stakeholders.

Many congratulations to the winners and finalists:

Best Therapeutic R&D Programme of the Year
⭐Winner: Resolution Therapeutics⭐
Finalists: Serenatis Bio, TRIMTECH Therapeutics

Pioneer Group Responds to Parliamentary Findings with New Insights into UK Innovation Economy

New parliamentary scrutiny of the UK’s innovation landscape has reinforced longstanding concerns about how investment in innovation is distributed across the country, with Pioneer Group, a specialist in technology infrastructure and venture building, urging swift action to address persistent barriers to research commercialisation.

Scientist/Senior Scientist (Bioscience)

About Sygnature Discovery

At Sygnature Discovery, we create exceptional scientific outcomes. For our customers, who bring life-changing medicines to patients; and for our people, who help make this possible.

We’re 700+ scientists from over 50 countries, working as one across Europe and North America. With no competing internal programs, we offer total confidentiality and commitment.

Protect Your Business Before It’s Too Late: Game-Changing Cyber Resilience

In this webinar, you will learn how to protect your organisation and clients against rising cyber threats, using AI and automation to enhance resilience while reducing operational costs.

Building and maintaining a Security Operations Centre (SOC) can cost upwards of £2 million. Managed Detection and Response (MDR) is rapidly becoming the default model for resilient, cost-effective cyber defence, delivering the same enterprise-grade security capabilities as a fully staffed SOC at a fraction of the cost.

Mestag Therapeutics Announces $40 Million Financing and Appoints Chief Medical Officer and Chief Development Officer in Preparation to Enter the Clinic

— Financing brings total funds committed to date to >$95 million

— Proceeds support the STARLYS clinical trial evaluating targeted LTBR agonist MST-0312 in solid tumors, together with platform and pipeline activities in inflammatory diseases

— Expands the leadership team with exceptional development executives to propel the clinical advancement of the pipeline

Subscribe to